Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer

2015; Termedia Publishing House; Volume: 5; Linguagem: Inglês

10.5114/jcb.2015.54952

ISSN

1689-832X

Autores

Lucas Gomes Sapienza, A. Aiza, Maria José Leite Gomes, Michael Chen, Antônio Cássio Assis Pellizzon, David B. Mansur, Glauco Baiocchi,

Tópico(s)

Endometriosis Research and Treatment

Resumo

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Sapienza L, Aiza A, Gomes M, et al. Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer. Journal of Contemporary Brachytherapy. 2015;7(5):357-362. doi:10.5114/jcb.2015.54952. APA Sapienza, L., Aiza, A., Gomes, M., Chen, M., Pellizzon, A., & Mansur, D. et al. (2015). Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer. Journal of Contemporary Brachytherapy, 7(5), 357-362. https://doi.org/10.5114/jcb.2015.54952 Chicago Sapienza, Lucas Gomes, Antonio Aiza, Maria José Leite Gomes, Michael Jenwei Chen, Antonio Cassio de Assis Pellizzon, David B. Mansur, and Glauco Baiocchi. 2015. "Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer". Journal of Contemporary Brachytherapy 7 (5): 357-362. doi:10.5114/jcb.2015.54952. Harvard Sapienza, L., Aiza, A., Gomes, M., Chen, M., Pellizzon, A., Mansur, D., and Baiocchi, G. (2015). Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer. Journal of Contemporary Brachytherapy, 7(5), pp.357-362. https://doi.org/10.5114/jcb.2015.54952 MLA Sapienza, Lucas Gomes et al. "Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer." Journal of Contemporary Brachytherapy, vol. 7, no. 5, 2015, pp. 357-362. doi:10.5114/jcb.2015.54952. Vancouver Sapienza L, Aiza A, Gomes M, Chen M, Pellizzon A, Mansur D et al. Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer. Journal of Contemporary Brachytherapy. 2015;7(5):357-362. doi:10.5114/jcb.2015.54952.

Referência(s)